Trial watch: Tumor-targeting monoclonal antibodies for oncological indications-Reference-Cited by-同舟云学术

Trial watch: Tumor-targeting monoclonal antibodies for oncological indications

Published:2015-01-02 Issue:1 Volume:4 Page:e985940
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Vacchelli Erika,Pol Jonathan,Bloy Norma,Eggermont Alexander,Cremer Isabelle,Fridman Wolf Hervé,Galon Jérôme,Marabelle Aurélien,Kohrt Holbrook,Zitvogel Laurence,Kroemer Guido,Galluzzi Lorenzo

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/2162402X.2014.985940

Reference193 articles.

1. Monoclonal antibodies: the story of a discovery that revolutionized science and medicine

2. Monoclonal antibodies: versatile platforms for cancer immunotherapy

3. Trial Watch

4. Novel immune checkpoint blocker approved for the treatment of advanced melanoma

5. Trial watch

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation;Cells;2022-11-29

2. Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer;Nature Communications;2022-11-04

3. Monoclonal Antibody and Targeted Toxin Therapy;Holland‐Frei Cancer Medicine;2022-10-21

4. Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy;Cancer Immunology, Immunotherapy;2022-10-19

5. Monoclonal antibodies for the treatment of acute lymphocytic leukemia: A literature review;Human Antibodies;2022-08-26